[
  {
    "NCT ID": "NCT02876419",
    "Brief Title": "A Long Term Follow-up Study of Patients From the REP 301 Protocol",
    "Official Title": "A Long Term Follow-up Study of Patients From the REP 301 Protocol",
    "Status": "COMPLETED",
    "Current Phase": null,
    "Start Date": "2016-08-01T00:00:00",
    "Completion Date": "2019-12-01T00:00:00",
    "Primary Completion Date": "2019-11-13T00:00:00",
    "Conditions": "Hepatitis B, Chronic; Hepatitis D, Chronic",
    "Interventions": "",
    "Sponsors": "Replicor Inc.",
    "Locations": "",
    "Study Type": "INTERVENTIONAL",
    "Enrollment": null,
    "Study Population": null
  },
  {
    "NCT ID": "NCT01449071",
    "Brief Title": "Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)",
    "Official Title": "A Phase1/2, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Pharmacokinetics of One 12 Week Treatment Cycle of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects With Moderate to Severe Disease",
    "Status": "COMPLETED",
    "Current Phase": "PHASE1, PHASE2",
    "Start Date": "2011-10-01T00:00:00",
    "Completion Date": "2013-03-01T00:00:00",
    "Primary Completion Date": "2013-03-01T00:00:00",
    "Conditions": "Systemic Lupus Erythematosus",
    "Interventions": "",
    "Sponsors": "UCB Pharma",
    "Locations": "",
    "Study Type": "INTERVENTIONAL",
    "Enrollment": null,
    "Study Population": null
  },
  {
    "NCT ID": "NCT04058964",
    "Brief Title": "Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer",
    "Official Title": "A Pilot Study to Assess the Efficacy and Safety Effects of Pembrolizumab and PEGPH20 (Pegvorhyaluronidase Alfa) in Patients With Metastatic Pancreatic Cancer",
    "Status": "WITHDRAWN",
    "Current Phase": "PHASE2",
    "Start Date": "2020-02-01T00:00:00",
    "Completion Date": "2022-10-31T00:00:00",
    "Primary Completion Date": "2022-10-31T00:00:00",
    "Conditions": "Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8",
    "Interventions": "",
    "Sponsors": "M.D. Anderson Cancer Center",
    "Locations": "",
    "Study Type": "INTERVENTIONAL",
    "Enrollment": null,
    "Study Population": null
  }
]